About 254,868 Worth Of Ardelyx Inc. (ARDX) Shares Belongs To Its

BEPC Stock
BEPC Stock

As of Wednesday close, Ardelyx Inc.’s (NASDAQ:ARDX) stock was down -$0.08, moving down -4.32 percent to $1.77. The average number of shares traded per day over the past five days has been 51,835,719 shares. 2 times new highs have been achieved over the past 5 days, with a $0.5500 gain in that time frame. In the last twenty days, the average volume was 17,661,984, while in the previous 50 days, it was 8,671,884.

Since last month, ARDX stock rose 23.78%. Shares of the company fell to $1.1600 on 11/15/22, the lowest level in the past month. A 52-week high of $2.19 was reached on 11/18/22 after having rallying from a 52-week low of $0.49. Since the beginning of this year, ARDX’s stock price has risen by 60.91% or $0.6700, and marked a new high 9 times. However, the stock has declined by -19.18% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


ARDX stock investors should be aware that Ardelyx Inc. (ARDX) stock had its last reported insider trading activity 3 days ago on Nov 22. GRAMMER ELIZABETH A, the of the company, disposed of 1,242 shares for $1.95 on Nov 22. It resulted in a $2,421 divestment by the insider. RAAB MICHAEL sold 6,219 shares at an average price of $1.95 on Nov 22. The insider now owns 659,461 shares following the transaction. On Nov 22, Chief Medical Officer Williams Laura A sold 1,241 shares at $1.95 apiece. The transaction was valued at $2,419.

Valuation Metrics

The stock’s beta is 1.45. Besides these, the trailing price-to-sales (P/S) ratio of 30.48, the price-to-book (PB) ratio of 4.42.

Financial Health

In the three months ended June 29, Ardelyx Inc.’s quick ratio stood at 2.30, while its current ratio was 2.30, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 89.40% percent. Based on annual data, ARDX earned $9.1 million in gross profit and brought in $10.1 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -134.30%. Return on equity (ROE) for the past 12 months was -171.20%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ARDX’s revenue rose 73.75% to $0.47 million during the quarter, while net income inched up to $4.99 million. While analysts expected Ardelyx Inc. to report -$0.19 quarterly earnings, the actual figure was -$0.19 per share. During the quarter, the company generated -$21.6 million in EBITDA. The liabilities of Ardelyx Inc. were 77.81 million at the end of its most recent quarter ended June 29, and its total debt was $37.92 million. The value of shareholders’ equity is $187.46 million.

Technical Picture

This quick technical analysis looks at Ardelyx Inc.’s (ARDX) price momentum. With a historical volatility rate of 206.60%, the RSI 9-day stood at 59.40% on 23 November.

With respect to its five-day moving average, the current Ardelyx Inc. price is up by +45.08% percent or $0.5500. At present, ARDX shares trade +30.15% above its 20-day simple moving average and +197.98% percent above its 100-day simple moving average. However, the stock is currently trading approximately +22.92% above its SMA50 and +123.46% above its SMA200.

Stochastic coefficient K was 71.52% and Stochastic coefficient D was 78.35%, while ATR was 0.2409. Given the Stochastic reading of 59.22% for the 14-day period, the RSI (14) reading has been calculated as 59.38%. As of today, the MACD Oscillator reading stands at 0.2867, while the 14-day reading stands at 0.3695.

Analyst Ratings

Piper Sandler upgraded its rating on Ardelyx Inc. (NASDAQ: ARDX) to an Overweight in a note to investors on November 17, 2022. The analysts firm previously had a Neutral rating on the stock.Ardelyx Inc. (ARDX) has been rated Overweight by analysts. According to 0 brokerage firms, ARDX is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Ardelyx Inc. stock as buy, with 5 recommending it as overweight.

With a median target price of $6.00, the current consensus forecast for the stock is $1.60 – $8.00. Based on these forecasts, analysts predict Ardelyx Inc. (ARDX) will achieve an average price target of $5.18.


Please enter your comment!
Please enter your name here